Name: identification of transcription factor regulators using medium-throughput screening of arrayed libraries and a dual-luciferase-based reporter
Uploaded: 2020-03-27T13:00:00
Description: Watch this Scientific Journal Video about Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter at JoVE.com

We would like to thank Emily Norton and Mikaelan Cucciarre-Stuligross for assisting in the preparation of shRNA vectors. This work was supported in part by a Susan G. Komen Career Catalyst Grant that awarded to J.M.L. (#CCR17477184).

NOTE: A schematic summary of this protocol is shown in Figure 1.
1. Lentiviral vector library preparation
NOTE: The demonstrated screen used an arrayed shRNA library purchased as glycerol stocks in 96-well plates, but libraries can also be assembled manually based on a list of candidates. Appropriate controls should be considered and included in any library. This includes a non-targeting control shRNA (shNTC), a control shRNA targeting th...

In this study, we demonstrate an approach for medium-throughput screening of arrayed viral libraries in combination with a dual-luciferase-based transcriptional reporter assay that can be used to identify and test novel regulators of transcription factors. It is critical to characterize and optimize the reporter system for each cell line prior to any screen. Experiments should be done to confirm that the reporter is responsive to altered activity of the transcription factor being investigated and the magnitude of change ...

The purpose of this assay is to use viral libraries to identify regulators of transcription factors in a relatively quick and inexpensive manner. Aberrant transcriptional activity is associated with cancer and metastasis1,2,3,4,5,6, so targeting transcription factors in cancer cells is a promising therapeutic approach. However, transcription factors are often difficult to target pharmacologically7 and many are required for normal cellular function in adult tissues8,9,10. Targeting the cancer-associated pathways that aberrantly activate transcription factors to drive disease is a more feasible approach with the potential to have less severe side effects. The commercial availability of arrayed lentiviral and retroviral RNAi, CRISPR/CAS9, cDNA, or ORF libraries allows researchers to test the importance of numerous genes in a single experiment. However, a reliable readout for altered transcriptional activity is required.
Here, we describe the use of a dual-luciferase-based transcriptional reporter assay and arrayed lentiviral libraries to identify proteins that regulate transcription factors in cancer cells. In this assay, shRNAs that target cancer-associated genes are delivered to mammalian cancer cells via lentiviral transduction and cells are selected for stable integration using puromycin. The cells are next transfected with a reporter construct that expresses firefly luciferase driven by a promoter specific to the transcription factor that is being investigated and a control construct that expresses Renilla luciferase from a constitutively active promoter that is not responsive to the transcription factor being investigated. We demonstrate this approach with a proof-of-concept screen for regulators of YAP and TAZ, the critical downstream effectors of the Hippo pathway8,10,11. Abnormal activity of YAP and TAZ promotes several steps of the metastatic cascade11 and is observed in many cancers11,12,13. However, how YAP and TAZ become aberrantly activated in some cancer cells is not yet fully understood. YAP and TAZ do not bind DNA, but instead are recruited to promoters by other transcription factors. Members of the TEA domain (TEAD) family of transcription factors are the major binding partners for YAP and TAZ, and are critical for most YAP and TAZ-dependent functions. Our reporter construct expresses firefly luciferase from a YAP/TAZ-TEAD-responsive promoter and previous studies have demonstrated that it faithfully detects changes in YAP-TEAD and TAZ-TEAD transcriptional activity2,14,15.
Our approach is rapid, medium-throughput, and does not require screening facilities, automated robots, or deep sequencing of pooled libraries. The costs are relatively low and there are numerous commercially available libraries to choose from. The required equipment and reagents are also relatively standard in most laboratories. It can be used to screen for regulators of virtually any transcription factor if a luciferase-based reporter exists or is generated. We use this approach to screen shRNAs in cancer cells, but any cell line that can be transfected with reasonable efficiency could be used with any type of arrayed library.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>2.0 ml 96-well deep well polypropylene plate</td>
			<td>USA Scientific</td>
			<td>1896-2000</td>
			<td>For bacterial mini-prep</td>
		</tr>
		<tr>
			<td>Trypsin - 2.50%</td>
			<td>Gibco</td>
			<td>15090-046</td>
			<td>Component of trypsin-EDTA</td>
		</tr>
		<tr>
			<td>96 well flat bottom white assay plate</td>
			<td>Corning</td>
			<td>3922</td>
			<td>For dual-luciferase assay</td>
		</tr>
		<tr>
			<td>Ampicillin - 100 mg/ml</td>
			<td>Sigma-Aldrich</td>
			<td>45-10835242001-EA</td>
			<td>For bacterial mini-prep</td>
		</tr>
		<tr>
			<td>Bacto-tryptone - powder</td>
			<td>Sigma-Aldrich</td>
			<td>95039</td>
			<td>Component of LB broth</td>
		</tr>
		<tr>
			<td>Dual-luciferase reporter assay system, which include LAR II reagent (reagent A), Stop &#38; Glo substrate (reagent B substrate) and Stop &#38; Glo buffer (reagent B buffer) - Kit</td>
			<td>Promega</td>
			<td>E1960</td>
			<td>For dual-luciferase assay</td>
		</tr>
		<tr>
			<td>Dulbecco&#39;s phosphate buffered saline w/o calcium, magnesium and phenol red - 9.6 g/L</td>
			<td>Himedia</td>
			<td>TS1006</td>
			<td>For PBS</td>
		</tr>
		<tr>
			<td>EDTA - 0.5 M</td>
			<td>VWR</td>
			<td>97061-406</td>
			<td>Component of trypsin-EDTA</td>
		</tr>
		<tr>
			<td>Ethanol - 100%</td>
			<td>Pharmco-AAPER</td>
			<td>111000200</td>
			<td>For bacterial mini-prep</td>
		</tr>
		<tr>
			<td>Foetal Bovine Serum - 100%</td>
			<td>VWR</td>
			<td>97068-085</td>
			<td>Component of complete growth media</td>
		</tr>
		<tr>
			<td>Hexadimethrine bromide (Polybrene) - 8 mg/ml</td>
			<td>Sigma-Aldrich</td>
			<td>45-H9268</td>
			<td>For virus infection</td>
		</tr>
		<tr>
			<td>HyClone DMEM/High glucose - 4 mM L-Glutamine; 4500 mg/L glucose; sodium pyruvate</td>
			<td>GE Healthcare life sciences</td>
			<td>SH30243.01</td>
			<td>Component of complete growth media</td>
		</tr>
		<tr>
			<td>I3-P/i3 Multi-Mode Microplate/EA</td>
			<td>Molecular devices</td>
			<td></td>
			<td>For dual-luciferase assay</td>
		</tr>
		<tr>
			<td>L-Glutamine - 200 mM</td>
			<td>Gibco</td>
			<td>25030-081</td>
			<td>Component of complete growth media</td>
		</tr>
		<tr>
			<td>Lipofectamine 3000 (Transfection Reagent 2) - 100%</td>
			<td>Life technologies</td>
			<td>L3000008</td>
			<td>For transfections</td>
		</tr>
		<tr>
			<td>Molecular Biology Water - 100%</td>
			<td>VWR</td>
			<td>02-0201-0500</td>
			<td>For dilution of shRNA vector for virus packaging</td>
		</tr>
		<tr>
			<td>NaCl - powder</td>
			<td>BDH</td>
			<td>BDH9286</td>
			<td>Component of LB broth</td>
		</tr>
		<tr>
			<td>NanoDrop One Microvolume UV-Vis Spectrophotometer</td>
			<td>Thermo scientific</td>
			<td></td>
			<td>For measuring vector DNA concentration</td>
		</tr>
		<tr>
			<td>Opti-MEM (Transfection Buffer) - 100%</td>
			<td>Gibco</td>
			<td>31985-062</td>
			<td>For transfections</td>
		</tr>
		<tr>
			<td>Penicillin Streptomycin - 10,000 Unit/ml (Penicillin); 10,000 &#181;g/ml (Streptomycin)</td>
			<td>Gibco</td>
			<td>15140-122</td>
			<td>Component of complete growth media</td>
		</tr>
		<tr>
			<td>PureLink Quick Plasmid Miniprep Kit - Kit</td>
			<td>Thermo Fisher Scientific</td>
			<td>K210010</td>
			<td>For bacterial mini-prep</td>
		</tr>
		<tr>
			<td>Puromycin - 2.5 mg/ml</td>
			<td>Sigma-Aldrich</td>
			<td>45-P7255</td>
			<td>For antibiotic selection after infection</td>
		</tr>
		<tr>
			<td>TC20 automated cell counter</td>
			<td>Bio-Rad</td>
			<td></td>
			<td>For cell counting</td>
		</tr>
		<tr>
			<td>X-tremeGENE 9 DNA transfection reagent (Transfection Reagent 1) - 100%</td>
			<td>Roche</td>
			<td>6365787001</td>
			<td>For virus packaging</td>
		</tr>
		<tr>
			<td>Yeast extract - powder</td>
			<td>VWR</td>
			<td>J850</td>
			<td>Component of LB broth</td>
		</tr>
		<tr>
			<td>P3000 (Transfection Reagent 3) - 100%</td>
			<td>Life technologies</td>
			<td>L3000008</td>
			<td>For transfections</td>
		</tr>
	</tbody>
</table>

identification of transcription factor regulators using medium-throughput screening of arrayed libraries and a dual-luciferase-based reporter

Transcription factors can alter the expression of numerous target genes that influence a variety of downstream processes making them good targets for anti-cancer therapies. However, directly targeting transcription factors is often difficult and can cause adverse side effects if the transcription factor is necessary in one or more adult tissues. Identifying upstream regulators that aberrantly activate transcription factors in cancer cells offers a more feasible alternative, particularly if these proteins are easy to drug. Here, we describe a protocol that can be used to combine arrayed medium-scale lentiviral libraries and a dual-luciferase-based transcriptional reporter assay to identify novel regulators of transcription factors in cancer cells. Our approach offers a quick, easy, and inexpensive way to test hundreds of genes in a single experiment. To demonstrate the use of this approach, we performed a screen of an arrayed lentiviral RNAi library containing several regulators of Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ), two transcriptional co-activators that are the downstream effectors of the Hippo pathway. However, this approach could be modified to screen for regulators of virtually any transcription factor or co-factor and could also be used to screen CRISPR/CAS9, cDNA, or ORF libraries.

Our YAP/TAZ-TEAD reporter construct (pGL3-5xMCAT (SV)-492,14,15) contains a minimal SV-49 promoter with 5 repeats of the canonical TEAD binding element (MCAT)15 driving the firefly luciferase gene (Figure 1). It is co-transfected into cells along with the PRL-TK control vector (Promega), which expresses Renilla luciferase from the con...

Watch this Scientific Journal Video about Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter at JoVE.com

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

To identify novel regulators of transcription factors, we developed an approach to screen arrayed lentiviral or retroviral RNAi libraries using a dual-luciferase-based transcriptional reporter assay. This approach offers a quick and relatively inexpensive way to screen hundreds of candidates in a single experiment.

Transcription factors can alter the expression of numerous target genes that influence a variety of downstream processes making them good targets for ...

This protocol can be used to screen arrayed lentiviral or retroviral assay libraries to identify novel regulators of transcription factors in cancer cells. The main advantages of this technique are that it is rapid, medium throughput, and inexpensive, and that it uses equipment and reagents commonly accessible to most investigators. To expand and purify each lentiviral vector in the library, first add 1.3 milliliters of Luria broth supplemented with 100 micrograms per milliliter of ampicillin to each well of a 96-well deep well plate.Inoculate each well with two microliters of glycerol stock for an overnight incubation at 37 degrees Celsius and 225 revolutions per minute. The next day, transfer each bacteria culture into individual 1.5 milliliter microcentrifuge tubes for centrifugation. Purify each vector with an appropriate bacterial miniprep kit according to the manufacturer's instructions.For each vector in the prepared library, seed one well of a 24-well plate with one times 10 to the fifth 293FT cells and incubate the cells at 37 degrees Celsius and 5%carbon dioxide for 24 hours. To prepare a transfection mixture which will be set up for each vector in the library, first elute each lentiviral vector to a final concentration of 50 nanograms per microliter with nuclease-free water. Transfer five microliters of each dilution into individual wells of a 96-well PCR plate.Make a transfection super mix by mixing 1.25 microliters times x of transfection reagent one with 23.75 microliters times x of pre-warmed transfection buffer. Incubate the transfection super mix at room temperature for five minutes. Then add 125 nanograms times x of psPAX2 and 125 nanograms times x of VSVG to the super mix with gentle pipetting.Immediately aliquot the super mix into each tube of a PCR strip and use a multichannel pipette to transfer 25 microliters of the mixture into each well of diluted viral vector. After a 20 minute incubation at room temperature, use a multichannel pipette to transfer 30 microliters of each transfection mixture from each well into a corresponding well of 293FT cells in the previously prepared 24-well plate. Incubate the cells for 24 hours before replacing the medium in each well with 500 microliters of fresh complete growth medium for another 24-hour incubation in the cell culture incubator.The next day, use a multichannel pipette to collect the viral supernatant from each well and aliquot 220 microliters of each supernatant into two wells in a new 96-well plate to generate an arrayed viral supernatant plate. To prepare A375 cells for infection, seed one times 10 to the fifth cells in a 24-well plate in 0.5 milliliters of complete growth medium per well for each viral vector in the library. Include an extra well that will not be infected to serve as a control for drug selection.After a 24-hour incubation in the cell culture incubator, thaw the frozen arrayed lentiviral supernatant set to room temperature before replacing the growth medium from each well of the prepared cell culture plate with 200 microliters of growth medium supplemented with 20 micrograms per milliliter of polybrene. Using a multichannel pipette, transfer 200 microliters of viral supernatant from each 96 well to each well of the 24-well plate. Return the cells to the cell culture incubator for 24 to 48 hours.At the end of the incubation, replace the medium in each well with 500 microliters of growth medium supplemented with puromycin and return the cells to the cell culture incubator for an additional 48 hours. Following the 48-hour puromycin selection, sort the cells into three or four groups such that all of the wells in a single group have a similar cell density and add 200 microliters of trypsin-EDTA to one representative well from each group for a five-minute incubation at 37 degrees Celsius. Once the cells have detached, neutralize the trypsin with 400 microliters of growth medium supplemented with puromycin and count the number of cells from each trypsinized well.Dilute each cell suspension to a two times 10 to the fifth cells per milliliter concentration with growth medium supplemented with puromycin and seed 500 microliters of cells from each well into the same well position in a new 24-well plate. After using the counts from each representative well to estimate the cell number in each remaining well in each group, add the appropriate volume of trypsin-EDTA to each well to achieve a one times 10 to the sixth cells per milliliter concentration. During the trypsinization, use a multichannel pipette to add 400 microliters of growth medium supplemented with puromycin to the appropriate corresponding wells in the new 24-well plate.Once cells have detached, gently mix the contents of each well and transfer 100 microliters of each cell suspension to the appropriate corresponding well in the new 24-well plate. Then return the cells to the cell culture incubator for 24 hours. To transfect the cells with the dual-luciferase reporter constructs, prepare the transfection dilution mixture as indicated in the table.To prepare the reporter dilution mixture, mix the volumes of each reagent multiplied by the total number of transfections plus several extra volumes. Next, mix the transfection dilution mixture with the reporter dilution mixture and incubate the resulting solution at room temperature for 15 minutes to produce the transfection mixture. During the incubation, rinse each well of the cell culture plate with 250 microliters of PBS and add 447 microliters of fresh complete growth medium to each well.Then use a multichannel pipette to distribute 53 microliters of transfection mix to each well of the cell culture plate. Place the plate at 37 degrees Celsius and 5%carbon dioxide for 24 hours. To measure the luciferase activity, dilute 5X passive lysis buffer from the luciferase activity kit at a one-to-five dilution with deionized water and thaw the necessary volumes of reagent A and reagent B buffer from the kit.When the reagents are ready, replace the supernatant in each well with 75 microliters of passive lysis buffer and incubate the plate for 30 minutes at room temperature with occasional shaking. During the incubation, dilute the 50X reagent B substrate from the kit to a one-to-50 concentration with thawed reagent B buffer. At the end of the incubation, add 30 microliters of passive lysis buffer to four blank control wells and transfer 30 microliters of lysate from each well into duplicate wells of a 96-well flat bottom white assay plate.When all of the lysate has been plated, use a multichannel pipette to add 50 microliters of reagent A to each well and read the firefly luciferase signal with a plate reader. Then use a multichannel pipette to add 50 microliters of reagent B to each well and read the Renilla luciferase signal with a plate reader. As expected, YAP2SA increases firefly luciferase activity but not Renilla luciferase activity as compared to the control vector.In contrast, YAP2SA S94A does not increase firefly luciferase activity. Importantly, YAP2SA does not alter the activity of a minimal promoter construct that lacks the MCAT TEAD binding elements. In cells transfected with the YAP-TAZ-TEAD reporter construct, the tandem YAP and TAZ short hairpins significantly reduced firefly luciferase levels, but the control short hairpin non-targeting control does not.In contrast, in cells transfected with the minimal reporter construct, the YAP-TAZ short hairpin RNA does not significantly alter firefly luciferase levels. The Renilla signal in each well is also not significantly altered by the short hairpin non-targeting control or the YAP-TAZ short hairpin RNA. As expected, short hairpin RNAs targeting YAP and TAZ, SARC or PI3 kinase significantly reduces YAP-TAZ-TEAD activity.Short hairpin RNAs targeting ATM, CDH1, CSK, ERBB2, and gelsolin each increased normalized firefly luciferase levels consistent with published studies showing that these proteins were YAP and/or TAZ. Despite established roles for ATR, CCNE2, and ERBB4 in other cell types, short hairpin RNAs targeting these genes do not significantly change normalized firefly luciferase levels in A375 cells. Following this screen, identifying regulators should be validated using other readouts for their transcription factor activity.Effective knockdown of the identified regulator by the assay should also be confirmed. Remember to use caution and to follow safety guidelines when working with infectious lentiviruses, particularly if the viruses are human infectious.

Research

JoVE Journal

Cancer Research

Sectioning Mammary Gland Whole Mounts for Lesion Identification

Normal mammary gland development may be altered by exposure to environmental toxicants and pharmaceutical products, excessive exposure to hormones, and ...

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Glioblastoma (GBM) is the most common and most lethal primary brain tumor in adults, causing roughly 14,000 deaths each year in the U.S. alone. Median ...

Live Cell Imaging of the TGF-	&beta;/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Transforming Growth Factor &#946; (TGF-&#946;) signaling regulates many important functions required for cellular homeostasis and is commonly found ...

Analysis of Cancer Cell Invasion and Anti-metastatic Drug Screening Using Hydrogel Micro-chamber Array (HMCA)-based Plates

Analysis of Cancer Cell Invasion and Anti-metastatic Drug Screening Using Hydrogel Micro-chamber Array HMCA-based Plates

Cancer metastasis is known to cause 90% of cancer lethality. Metastasis is a multistage process which initiates with the penetration/invasion of tumor ...

Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells

Embryonic stem cells (ESCs) are pluripotent stem cells capable of self-renewal and differentiation into all types of embryonic cells. Like many other cell ...

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids

Small bowel neuroendocrine tumors (SBNETs) are rare cancers originating from enterochromaffin cells of the gut. Research in this field has been limited ...

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Many cancers are characterized by chromosomal translocations which result in the expression of oncogenic fusion transcription factors. Typically, these ...

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

The changes in the plasma membrane localization of the epidermal growth factor receptor (EGFR) and its downstream effector RAS have been implicated in ...

Discovery of Metastatic Regulators using a Rapid and Quantitative Intravital Chick Chorioallantoic Membrane Model

Recent advances in cancer research has illustrated the highly complex nature of cancer metastasis. Multiple genes or genes networks have been found to be ...

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

The glioma stem cells (GSCs) are a small fraction of cancer cells which play essential roles in tumor initiation, angiogenesis, and drug resistance in ...